Bank of America’s Usana Health Sciences USNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $751K | Sell |
43,005
-30,884
| -42% | -$613K | ﹤0.01% | 4673 |
|
|
2025
Q4 | $1.45M | Sell |
73,889
-39,250
| -35% | -$814K | ﹤0.01% | 4298 |
|
|
2025
Q3 | $3.12M | Buy |
113,139
+40,274
| +55% | +$1.24M | ﹤0.01% | 4433 |
|
|
2025
Q2 | $2.22M | Buy |
72,865
+18,244
| +33% | +$518K | ﹤0.01% | 4677 |
|
|
2025
Q1 | $1.47M | Buy |
54,621
+35,233
| +182% | +$1.12M | ﹤0.01% | 4947 |
|
|
2024
Q4 | $696K | Buy |
19,388
+5,188
| +37% | +$194K | ﹤0.01% | 5307 |
|
|
2024
Q3 | $538K | Sell |
14,200
-1,252
| -8% | -$51.4K | ﹤0.01% | 5438 |
|
|
2024
Q2 | $699K | Buy |
15,452
+4,122
| +36% | +$190K | ﹤0.01% | 5128 |
|
|
2024
Q1 | $550K | Sell |
11,330
-2,792
| -20% | -$137K | ﹤0.01% | 5291 |
|
|
2023
Q4 | $757K | Sell |
14,122
-19,703
| -58% | -$997K | ﹤0.01% | 5196 |
|
|
2023
Q3 | $1.98M | Buy |
33,825
+15,626
| +86% | +$977K | ﹤0.01% | 4249 |
|
|
2023
Q2 | $1.15M | Sell |
18,199
-5,026
| -22% | -$320K | ﹤0.01% | 4672 |
|
|
2023
Q1 | $1.46M | Buy |
23,225
+3,192
| +16% | +$190K | ﹤0.01% | 4620 |
|
|
2022
Q4 | $1.07M | Buy |
20,033
+10,162
| +103% | +$551K | ﹤0.01% | 4805 |
|
|
2022
Q3 | $554K | Sell |
9,871
-4,072
| -29% | -$269K | ﹤0.01% | 5319 |
|
|
2022
Q2 | $1.01M | Sell |
13,943
-8,687
| -38% | -$647K | ﹤0.01% | 4897 |
|
|
2022
Q1 | $1.8M | Sell |
22,630
-1,510
| -6% | -$136K | ﹤0.01% | 4687 |
|
|
2021
Q4 | $2.44M | Buy |
24,140
+4,184
| +21% | +$417K | ﹤0.01% | 4357 |
|
|
2021
Q3 | $1.84M | Buy |
19,956
+3,130
| +19% | +$301K | ﹤0.01% | 4517 |
|
|
2021
Q2 | $1.72M | Sell |
16,826
-9,299
| -36% | -$934K | ﹤0.01% | 4452 |
|
|
2021
Q1 | $2.55M | Buy |
26,125
+10,711
| +69% | +$975K | ﹤0.01% | 4042 |
|
|
2020
Q4 | $1.19M | Buy |
15,414
+870
| +6% | +$67.3K | ﹤0.01% | 4363 |
|
|
2020
Q3 | $1.07M | Sell |
14,544
-5,723
| -28% | -$459K | ﹤0.01% | 4152 |
|
|
2020
Q2 | $1.49M | Buy |
20,267
+8,186
| +68% | +$642K | ﹤0.01% | 3829 |
|
|
2020
Q1 | $698K | Buy |
12,081
+1,404
| +13% | +$97.7K | ﹤0.01% | 4274 |
|
|
2019
Q4 | $839K | Sell |
10,677
-14,627
| -58% | -$1.08M | ﹤0.01% | 4626 |
|
|
2019
Q3 | $1.73M | Sell |
25,304
-5,801
| -19% | -$390K | ﹤0.01% | 4169 |
|
|
2019
Q2 | $2.47M | Sell |
31,105
-34,589
| -53% | -$2.74M | ﹤0.01% | 3872 |
|
|
2019
Q1 | $5.51M | Buy |
65,694
+31,137
| +90% | +$3.25M | ﹤0.01% | 3074 |
|
|
2018
Q4 | $4.07M | Buy |
34,557
+20,835
| +152% | +$2.41M | ﹤0.01% | 3217 |
|
|
2018
Q3 | $1.65M | Sell |
13,722
-8,104
| -37% | -$1.01M | ﹤0.01% | 4136 |
|
|
2018
Q2 | $2.52M | Buy |
21,826
+2,540
| +13% | +$278K | ﹤0.01% | 3794 |
|
|
2018
Q1 | $1.66M | Sell |
19,286
-9,817
| -34% | -$760K | ﹤0.01% | 4021 |
|
|
2017
Q4 | $2.15M | Buy |
29,103
+28,010
| +2,563% | +$1.87M | ﹤0.01% | 3885 |
|
|
2017
Q3 | $63K | Buy |
1,093
+243
| +29% | +$14.4K | ﹤0.01% | 5849 |
|
|
2017
Q2 | $54K | Sell |
850
-6,714
| -89% | -$414K | ﹤0.01% | 5845 |
|
|
2017
Q1 | $436K | Sell |
7,564
-905
| -11% | -$54K | ﹤0.01% | 4956 |
|
|
2016
Q4 | $518K | Sell |
8,469
-1,473
| -15% | -$96K | ﹤0.01% | 4773 |
|
|
2016
Q3 | $688K | Sell |
9,942
-30,734
| -76% | -$2.03M | ﹤0.01% | 4413 |
|
|
2016
Q2 | $2.27M | Buy |
40,676
+39,886
| +5,049% | +$2.41M | ﹤0.01% | 3526 |
|
|
2016
Q1 | $48K | Sell |
790
-4,564
| -85% | -$269K | ﹤0.01% | 5809 |
|
|
2015
Q4 | $342K | Buy |
5,354
+4,996
| +1,396% | +$324K | ﹤0.01% | 5053 |
|
|
2015
Q3 | $24K | Sell |
358
-2,436
| -87% | -$172K | ﹤0.01% | 6251 |
|
|
2015
Q2 | $191K | Buy |
2,794
+878
| +46% | +$55.7K | ﹤0.01% | 5259 |
|
|
2015
Q1 | $106K | Buy |
+1,916
| New | +$98.2K | ﹤0.01% | 5282 |
|
|
2014
Q4 | – | Sell |
-4,992
| Closed | -$184K | – | 7982 |
|
|
2014
Q3 | $184K | Buy |
4,992
+2,712
| +119% | +$97.9K | ﹤0.01% | 5458 |
|
|
2014
Q2 | $89K | Buy |
2,280
+1,850
| +430% | +$68.7K | ﹤0.01% | 6224 |
|
|
2014
Q1 | $16K | Sell |
430
-17,068
| -98% | -$596K | ﹤0.01% | 7012 |
|
|
2013
Q4 | $661K | Buy |
17,498
+14,518
| +487% | +$556K | ﹤0.01% | 4505 |
|
|
2013
Q3 | $129K | Sell |
2,980
-13,338
| -82% | -$535K | ﹤0.01% | 5790 |
|
|
2013
Q2 | $591K | Buy |
+16,318
| New | +$496K | ﹤0.01% | 4592 |
|
Other funds holding USNA
NCM
VCM
VPM
Bank of America's USNA Position: Q1 2026 in Review
Bank of America reduced its Usana Health Sciences (USNA) stake by 42% in Q1 2026, selling an estimated $613K and leaving 43,005 shares worth $751K. The position accounts for ﹤0.01% of the portfolio, ranked #4673.
Bank of America first reported a position in USNA in Q2 2013 and has held it in 51 quarters since. The position peaked at $5.51M in Q1 2019. 139 funds tracked by Wall St. Rank hold USNA as of Q1 2026.
- Bank of America held 43,005 shares of Usana Health Sciences worth $751K as of Q1 2026.
- Bank of America sold 30,884 Usana Health Sciences shares in Q1 2026, an estimated $613K.
- Usana Health Sciences made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #4673 holding.
- Bank of America first reported a position in Usana Health Sciences in Q2 2013 and has held it in 51 quarters since.
- Bank of America's Usana Health Sciences position peaked at $5.51M in Q1 2019.
- 139 funds tracked by Wall St. Rank held Usana Health Sciences as of Q1 2026.
Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.